The page is the record's research on the issuer — no analyst, no rating, no view. # REGENTIS BIOMATERIALS LTD. (NYSE: RGNT) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is REGENTIS BIOMATERIALS LTD., listed on the NYSE under ticker RGNT, with ISIN USM8211G1087. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-L3 was found. The security type is Non-operating entity type (other), the segment is not on the record, the sector is 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies, and the jurisdiction is Israel. The issuer is listed and not halted. ## The disclosure read The record holds 53 filings in the twelve months from 2025-11-08 to 2026-11-08, across 35 filing days. Of these, 15 are directors' dealings, 5 are prospectuses, 11 are regulatory filings, and 22 are results. The median gap between filing days is 6.0 days. The latest filing is dated 2026-10-13 and is of type results, and 26 days separate it from the record date of 2026-11-08. The NYSE median cadence gap is 6.0 days across 3256 issuers, with a median of 64.0 filings and a median latency of 4.0 days. The sector median cadence gap is 5 days across 27 issuers, with a median of 76 filings and a median latency of 3 days. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds one lifecycle line, a listing dated 2025-12-03. It holds no delisting, no name change, and no dated change of domicile; the domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The chapter was as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page, the count is zero. ## Open research No openly published research notes were found, and the count is zero. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2022, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. The market's vintage is sealed. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001912966.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/RGNT (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/RGNT (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/RGNT · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp